Skip to main content

$0.011 0.001 (10.00%)

High

$0.01

Low

$0.01

Trades

62

Turnover

$15,077

Volume

1,373,136
30 June 2023 at 4:10pm
Register to track LDX and receive email alerts.

U.S FDA Deprioritises EUA Application for CoviDx

StockBot

416,823 posts

LDX released this announcement to the ASX on 22 September 2021, 9:12. The announcement is marked as price sensitive, and is 2 page(s) in length and 156.2kb in size.

You can view all announcements from LDX and see how they appear on a price chart on the announcements page.

At the date of this announcement, LDX was 0.012% short sold according to ASIC data. It was ranked the 585th most shorted stock on the ASX. It remains ranked 616th as of the latest reported data (27 April 2026).

Other Recent Announcements from LDX
Change in substantial holding 9 June 2023, 11:17
Application for quotation of securities - LDX 6 June 2023, 16:57
Change in substantial holding from RYD 6 June 2023, 16:32
U.S FDA Deprioritises EUA Application for CoviDx 22 September 2021, 9:12
Change in substantial holding 20 September 2021, 16:59
Appointment of Dr. Jerome Adams as Strategic Health Adviser 14 September 2021, 9:14
Change in substantial holding 1 September 2021, 15:48
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track LDX and receive email alerts.